Innoviva INVA 深 沪
等待开盘 09-22 09:30:00 美东时间
19.19
-0.700
-3.52%
华盛通- 最 高20.06
- 今 开19.88
- 成交量 159.08万股
- 最 低 19.16
- 昨 收 19.89
- 总市值 12.05亿
- 52周最高 22.00
- 市盈率 静 53.00
- 换手率 0.00%
- 52周最低 16.67
- 委 比 -85.51%
- 总股本 6277.52万
- 历史最高 41.71
- 量 比 2.28
- 振 幅 4.52%
- 历史最低 6.36
- 每 手 1
- 风险率 1.93%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多生存恐怖游戏有哪些好玩 2024生存恐怖游戏排行榜前十
探寻2024年最令人胆寒的生存恐怖游戏盛宴！本文带你揭秘排行榜前十的刺激之作，从经典的逃生挑战到创新的技术革新，满足你对恐惧与紧张感的极致追求。无论是硬核玩家还...
08-27 11:14
A Look Ahead: Phibro Animal Health's Earnings Forecast
Phibro Animal Health (NASDAQ:PAHC) will release its quarterly earnings report o...
08-27 00:04
Congressional Trading Report: Rep. George Whitesides Sold Over $50K In Planet Labs Stock
Records from August 13, 2025 indicate that Representative George Whitesides of ...
08-14 23:00
Expert Outlook: Innoviva Through The Eyes Of 4 Analysts
During the last three months, 4 analysts shared their evaluations of Innoviva (...
08-12 02:01
HC Wainwright & Co. Maintains Buy on Innoviva, Raises Price Target to $45
HC Wainwright & Co. analyst Raghuram Selvaraju maintains Innoviva (NASDAQ:INVA) with a Buy and raises the price target from $40 to $45.
08-11 18:41
A Preview Of Harrow's Earnings
Harrow (NASDAQ:HROW) will release its quarterly earnings report on Monday, 2025...
08-08 23:05
鼎优乐短期仍存短缺问题 再鼎医药预计旗下PARP抑制剂一线份额将扩大|直击业绩会
①今日举行的业绩会中，再鼎医药管理层对部分主要产品销售情况以及下半年业绩展望做出了介绍； ②再鼎医药还就鼎优乐药物短缺问题，以及肿瘤类、精神类药物管线进展和商业化布局等问题做出了回应。
08-08 16:02
Innoviva Q2 EPS $0.77 Beats $0.49 Estimate, Sales $100.283M Beat $87.130M Estimate
Innoviva (NASDAQ:INVA) reported quarterly earnings of $0.77 per share which beat the analyst consensus estimate of $0.49 by 57.14 percent. This is a 240 percent increase over losses of $(0.55) per share from the same
08-07 05:12
Insights into WAVE Life Sciences's Upcoming Earnings
WAVE Life Sciences (NASDAQ:WVE) is preparing to release its quarterly earnings ...
07-30 05:01
FDA将任命生物技术老将为首席药品监管官 审批速度、广告监管或遇转机
据一位知情人士透露，美国食品药品监督管理局（FDA）局长马蒂·马卡里已选定前生物技术高管乔治·蒂德马什担任该局首席药品监管官。
07-21 20:34
